Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.04
AMSG's Cash to Debt is ranked lower than
88% of the 237 Companies
in the Global Medical Care industry.

( Industry Median: 0.36 vs. AMSG: 0.04 )
Ranked among companies with meaningful Cash to Debt only.
AMSG' s Cash to Debt Range Over the Past 10 Years
Min: 0.04  Med: 0.13 Max: 0.71
Current: 0.04
0.04
0.71
Equity to Asset 0.35
AMSG's Equity to Asset is ranked lower than
67% of the 230 Companies
in the Global Medical Care industry.

( Industry Median: 0.46 vs. AMSG: 0.35 )
Ranked among companies with meaningful Equity to Asset only.
AMSG' s Equity to Asset Range Over the Past 10 Years
Min: 0.31  Med: 0.51 Max: 0.77
Current: 0.35
0.31
0.77
Interest Coverage 10.10
AMSG's Interest Coverage is ranked higher than
61% of the 189 Companies
in the Global Medical Care industry.

( Industry Median: 6.08 vs. AMSG: 10.10 )
Ranked among companies with meaningful Interest Coverage only.
AMSG' s Interest Coverage Range Over the Past 10 Years
Min: 4.74  Med: 16.88 Max: 28.93
Current: 10.1
4.74
28.93
F-Score: 6
Z-Score: 1.46
M-Score: -2.26
WACC vs ROIC
4.17%
11.99%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 24.06
AMSG's Operating margin (%) is ranked higher than
93% of the 233 Companies
in the Global Medical Care industry.

( Industry Median: 7.96 vs. AMSG: 24.06 )
Ranked among companies with meaningful Operating margin (%) only.
AMSG' s Operating margin (%) Range Over the Past 10 Years
Min: 24.06  Med: 31.80 Max: 35.12
Current: 24.06
24.06
35.12
Net-margin (%) 6.35
AMSG's Net-margin (%) is ranked higher than
58% of the 236 Companies
in the Global Medical Care industry.

( Industry Median: 5.01 vs. AMSG: 6.35 )
Ranked among companies with meaningful Net-margin (%) only.
AMSG' s Net-margin (%) Range Over the Past 10 Years
Min: 3.31  Med: 6.88 Max: 8.32
Current: 6.35
3.31
8.32
ROE (%) 8.37
AMSG's ROE (%) is ranked lower than
54% of the 215 Companies
in the Global Medical Care industry.

( Industry Median: 9.22 vs. AMSG: 8.37 )
Ranked among companies with meaningful ROE (%) only.
AMSG' s ROE (%) Range Over the Past 10 Years
Min: 4.03  Med: 9.79 Max: 11.84
Current: 8.37
4.03
11.84
ROA (%) 2.80
AMSG's ROA (%) is ranked lower than
58% of the 234 Companies
in the Global Medical Care industry.

( Industry Median: 3.95 vs. AMSG: 2.80 )
Ranked among companies with meaningful ROA (%) only.
AMSG' s ROA (%) Range Over the Past 10 Years
Min: 1.4  Med: 4.06 Max: 6.75
Current: 2.8
1.4
6.75
ROC (Joel Greenblatt) (%) 236.28
AMSG's ROC (Joel Greenblatt) (%) is ranked higher than
95% of the 232 Companies
in the Global Medical Care industry.

( Industry Median: 18.85 vs. AMSG: 236.28 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
AMSG' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 53.23  Med: 124.09 Max: 236.73
Current: 236.28
53.23
236.73
Revenue Growth (3Y)(%) 19.20
AMSG's Revenue Growth (3Y)(%) is ranked higher than
89% of the 172 Companies
in the Global Medical Care industry.

( Industry Median: 7.70 vs. AMSG: 19.20 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
AMSG' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 10.3  Med: 15.80 Max: 20.9
Current: 19.2
10.3
20.9
EBITDA Growth (3Y)(%) 12.00
AMSG's EBITDA Growth (3Y)(%) is ranked higher than
65% of the 141 Companies
in the Global Medical Care industry.

( Industry Median: 8.30 vs. AMSG: 12.00 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
AMSG' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -6.8  Med: 11.90 Max: 40.6
Current: 12
-6.8
40.6
EPS Growth (3Y)(%) 18.70
AMSG's EPS Growth (3Y)(%) is ranked higher than
70% of the 122 Companies
in the Global Medical Care industry.

( Industry Median: 7.70 vs. AMSG: 18.70 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
AMSG' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -7.2  Med: 11.00 Max: 135.1
Current: 18.7
-7.2
135.1
» AMSG's 10-Y Financials

Financials (Next Earnings Date: 2016-05-03)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2015

AMSG Guru Trades in Q1 2015

Joel Greenblatt 10,617 sh (New)
Steven Cohen Sold Out
Paul Tudor Jones Sold Out
Jim Simons 146,569 sh (-8.61%)
» More
Q2 2015

AMSG Guru Trades in Q2 2015

Joel Greenblatt 14,914 sh (+40.47%)
Jim Simons Sold Out
» More
Q3 2015

AMSG Guru Trades in Q3 2015

Paul Tudor Jones 5,324 sh (New)
Steven Cohen 43,600 sh (New)
Jim Simons 3,769 sh (New)
Joel Greenblatt 156,158 sh (+947.06%)
» More
Q4 2015

AMSG Guru Trades in Q4 2015

Vanguard Health Care Fund 376,000 sh (New)
Jim Simons 174,269 sh (+4523.75%)
Joel Greenblatt 494,371 sh (+216.58%)
Paul Tudor Jones 13,284 sh (+149.51%)
Steven Cohen 11,500 sh (-73.62%)
» More
» Details

Insider Trades

Latest Guru Trades with AMSG

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Preferred stocks of Amsurg Corp

SymbolPriceYieldDescription
AMSGP152.503.45

Ratios

vs
industry
vs
history
P/E(ttm) 28.20
AMSG's P/E(ttm) is ranked lower than
54% of the 178 Companies
in the Global Medical Care industry.

( Industry Median: 26.42 vs. AMSG: 28.20 )
Ranked among companies with meaningful P/E(ttm) only.
AMSG' s P/E(ttm) Range Over the Past 10 Years
Min: 9.07  Med: 17.79 Max: 64.73
Current: 28.2
9.07
64.73
Forward P/E 18.90
AMSG's Forward P/E is ranked lower than
59% of the 75 Companies
in the Global Medical Care industry.

( Industry Median: 16.81 vs. AMSG: 18.90 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 28.09
AMSG's PE(NRI) is ranked lower than
55% of the 177 Companies
in the Global Medical Care industry.

( Industry Median: 26.00 vs. AMSG: 28.09 )
Ranked among companies with meaningful PE(NRI) only.
AMSG' s PE(NRI) Range Over the Past 10 Years
Min: 8.55  Med: 18.26 Max: 63.28
Current: 28.09
8.55
63.28
Price/Owner Earnings (ttm) 97.25
AMSG's Price/Owner Earnings (ttm) is ranked lower than
85% of the 89 Companies
in the Global Medical Care industry.

( Industry Median: 26.24 vs. AMSG: 97.25 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
AMSG' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 5.23  Med: 12.38 Max: 2282.33
Current: 97.25
5.23
2282.33
P/B 2.07
AMSG's P/B is ranked higher than
62% of the 214 Companies
in the Global Medical Care industry.

( Industry Median: 2.52 vs. AMSG: 2.07 )
Ranked among companies with meaningful P/B only.
AMSG' s P/B Range Over the Past 10 Years
Min: 0.93  Med: 1.74 Max: 3.06
Current: 2.07
0.93
3.06
P/S 1.56
AMSG's P/S is ranked higher than
50% of the 230 Companies
in the Global Medical Care industry.

( Industry Median: 1.57 vs. AMSG: 1.56 )
Ranked among companies with meaningful P/S only.
AMSG' s P/S Range Over the Past 10 Years
Min: 0.7  Med: 1.32 Max: 2.41
Current: 1.56
0.7
2.41
PFCF 8.50
AMSG's PFCF is ranked higher than
88% of the 112 Companies
in the Global Medical Care industry.

( Industry Median: 20.31 vs. AMSG: 8.50 )
Ranked among companies with meaningful PFCF only.
AMSG' s PFCF Range Over the Past 10 Years
Min: 1.92  Med: 4.84 Max: 44.58
Current: 8.5
1.92
44.58
POCF 7.50
AMSG's POCF is ranked higher than
78% of the 153 Companies
in the Global Medical Care industry.

( Industry Median: 14.87 vs. AMSG: 7.50 )
Ranked among companies with meaningful POCF only.
AMSG' s POCF Range Over the Past 10 Years
Min: 1.75  Med: 4.41 Max: 14.37
Current: 7.5
1.75
14.37
EV-to-EBIT 11.99
AMSG's EV-to-EBIT is ranked higher than
84% of the 178 Companies
in the Global Medical Care industry.

( Industry Median: 19.43 vs. AMSG: 11.99 )
Ranked among companies with meaningful EV-to-EBIT only.
AMSG' s EV-to-EBIT Range Over the Past 10 Years
Min: 3.5  Med: 7.20 Max: 15.7
Current: 11.99
3.5
15.7
EV-to-EBITDA 10.34
AMSG's EV-to-EBITDA is ranked higher than
70% of the 192 Companies
in the Global Medical Care industry.

( Industry Median: 13.63 vs. AMSG: 10.34 )
Ranked among companies with meaningful EV-to-EBITDA only.
AMSG' s EV-to-EBITDA Range Over the Past 10 Years
Min: 3.2  Med: 6.50 Max: 13
Current: 10.34
3.2
13
PEG 2.56
AMSG's PEG is ranked higher than
54% of the 76 Companies
in the Global Medical Care industry.

( Industry Median: 2.87 vs. AMSG: 2.56 )
Ranked among companies with meaningful PEG only.
AMSG' s PEG Range Over the Past 10 Years
Min: 0.32  Med: 1.16 Max: 15.54
Current: 2.56
0.32
15.54
Shiller P/E 43.69
AMSG's Shiller P/E is ranked lower than
75% of the 44 Companies
in the Global Medical Care industry.

( Industry Median: 31.64 vs. AMSG: 43.69 )
Ranked among companies with meaningful Shiller P/E only.
AMSG' s Shiller P/E Range Over the Past 10 Years
Min: 12.58  Med: 20.32 Max: 47.91
Current: 43.69
12.58
47.91
Current Ratio 1.37
AMSG's Current Ratio is ranked higher than
52% of the 223 Companies
in the Global Medical Care industry.

( Industry Median: 1.35 vs. AMSG: 1.37 )
Ranked among companies with meaningful Current Ratio only.
AMSG' s Current Ratio Range Over the Past 10 Years
Min: 1.37  Med: 3.07 Max: 4.31
Current: 1.37
1.37
4.31
Quick Ratio 1.32
AMSG's Quick Ratio is ranked higher than
53% of the 223 Companies
in the Global Medical Care industry.

( Industry Median: 1.26 vs. AMSG: 1.32 )
Ranked among companies with meaningful Quick Ratio only.
AMSG' s Quick Ratio Range Over the Past 10 Years
Min: 1.32  Med: 2.86 Max: 4.04
Current: 1.32
1.32
4.04
Days Inventory 41.10
AMSG's Days Inventory is ranked lower than
73% of the 165 Companies
in the Global Medical Care industry.

( Industry Median: 16.80 vs. AMSG: 41.10 )
Ranked among companies with meaningful Days Inventory only.
AMSG' s Days Inventory Range Over the Past 10 Years
Min: 10.86  Med: 12.24 Max: 42.64
Current: 41.1
10.86
42.64
Days Sales Outstanding 47.97
AMSG's Days Sales Outstanding is ranked lower than
57% of the 202 Companies
in the Global Medical Care industry.

( Industry Median: 43.55 vs. AMSG: 47.97 )
Ranked among companies with meaningful Days Sales Outstanding only.
AMSG' s Days Sales Outstanding Range Over the Past 10 Years
Min: 34.74  Med: 39.58 Max: 52.45
Current: 47.97
34.74
52.45
Days Payable 64.51
AMSG's Days Payable is ranked higher than
61% of the 157 Companies
in the Global Medical Care industry.

( Industry Median: 43.92 vs. AMSG: 64.51 )
Ranked among companies with meaningful Days Payable only.
AMSG' s Days Payable Range Over the Past 10 Years
Min: 18.16  Med: 21.18 Max: 65.73
Current: 64.51
18.16
65.73

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 0.65
AMSG's Price/Projected FCF is ranked higher than
91% of the 87 Companies
in the Global Medical Care industry.

( Industry Median: 1.76 vs. AMSG: 0.65 )
Ranked among companies with meaningful Price/Projected FCF only.
AMSG' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.27  Med: 0.59 Max: 2.66
Current: 0.65
0.27
2.66
Price/DCF (Earnings Based) 2.39
AMSG's Price/DCF (Earnings Based) is ranked lower than
85% of the 26 Companies
in the Global Medical Care industry.

( Industry Median: 1.69 vs. AMSG: 2.39 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.20
AMSG's Price/Median PS Value is ranked lower than
61% of the 184 Companies
in the Global Medical Care industry.

( Industry Median: 1.06 vs. AMSG: 1.20 )
Ranked among companies with meaningful Price/Median PS Value only.
AMSG' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.71  Med: 1.09 Max: 2.07
Current: 1.2
0.71
2.07
Price/Peter Lynch Fair Value 2.34
AMSG's Price/Peter Lynch Fair Value is ranked lower than
52% of the 46 Companies
in the Global Medical Care industry.

( Industry Median: 2.29 vs. AMSG: 2.34 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
AMSG' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.53  Med: 1.31 Max: 4.93
Current: 2.34
0.53
4.93
Earnings Yield (Greenblatt) (%) 8.30
AMSG's Earnings Yield (Greenblatt) (%) is ranked higher than
88% of the 220 Companies
in the Global Medical Care industry.

( Industry Median: 4.10 vs. AMSG: 8.30 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
AMSG' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 6.4  Med: 13.90 Max: 28.5
Current: 8.3
6.4
28.5
Forward Rate of Return (Yacktman) (%) 23.03
AMSG's Forward Rate of Return (Yacktman) (%) is ranked higher than
85% of the 102 Companies
in the Global Medical Care industry.

( Industry Median: 11.10 vs. AMSG: 23.03 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
AMSG' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: 3.7  Med: 25.90 Max: 58.7
Current: 23.03
3.7
58.7

More Statistics

Revenue(Mil) $2567
EPS $ 2.89
Beta0.60
Short Percentage of Float10.17%
52-Week Range $54.11 - 87.42
Shares Outstanding(Mil)54.72

Analyst Estimate

Dec16
Revenue(Mil)
EPS($) 4.30
EPS without NRI($) 4.30

Business Description

Industry: Health Care Providers » Medical Care
Compare:NYSE:MD, ASX:SHL, FRA:CLS1, NAS:ACHC, NAS:WOOF, SZSE:300015 » details
Traded in other countries:AJH.Germany,
AmSurg Corp was formed in 1992. The Company owns and operates short stay ambulatory surgery centers or "ASC"s in the United States. The Company acquires, develops and operates ASCs through the formation of strategic partnerships with physicians to serve the communities in its markets. The Company has developed its operating model to encourage physicians to affiliate with them. It operates 242 surgery centers in 34 states and the District of Columbia. As of December 31, 2013, 151 of its centers performed gastrointestinal endoscopy procedures, 48 centers were multi-specialty centers, 36 centers performed ophthalmology surgery procedures and seven centers performed orthopaedic procedures. The Company market its surgery centers directly to patients, referring physicians and third party payors, including health maintenance organizations, or "HMO"s, preferred provider organizations, or "PPO"s, other managed care organizations, and employers. The Company competes with hospitals and other surgery centers in recruiting physicians to utilize its surgery centers, for patients and for the opportunity to contract with payors. The healthcare industry is subject to extensive regulation by a number of governmental entities at the federal, state and local level.
» More Articles for AMSG

Headlines

Articles On GuruFocus.com
Howard Marks' Largest Trades in Second Quarter Sep 29 2015 
Howard Marks Buys 13 New Stocks in Q3 Nov 14 2014 
Weekly CFO Sells Highlight: V, SCLN, VR, AMSG Jun 25 2012 
AmSurg Corp: Free Cash Flow not what it seems (AMSG) Aug 04 2011 
Amsurg Corp. (AMSG) Executive VP & CFO Claire M Gulmi sells 30,000 Shares Mar 17 2011 
Amsurg Corp. (AMSG) Executive VP & CFO Claire M Gulmi sells 27,500 Shares Nov 12 2010 
Amsurg Corp. Reports Operating Results (10-Q) Nov 05 2010 
Amsurg Corp. Reports Operating Results (10-Q) May 09 2009 

More From Other Websites
AmSurg Corp. to Present at Deutsche Bank 41st Annual Healthcare Conference Apr 28 2016
AmSurg Corp. to Present at Deutsche Bank 41st Annual Healthcare Conference Apr 28 2016
AmSurg Poised on Strategic Buyouts, Rising Costs a Concern Apr 20 2016
Amsurg To Release Q1 Results On May 3 Apr 19 2016
AmSurg Corp. Sets Earnings Release and Conference Call Dates for First Quarter 2016 Results Apr 19 2016
AmSurg Corp. Sets Earnings Release and Conference Call Dates for First Quarter 2016 Results Apr 19 2016
AmSurg’s Physician Services Division – Sheridan – Acquires North Florida Anesthesia... Apr 04 2016
AmSurg’s Physician Services Division – Sheridan – Acquires North Florida Anesthesia... Apr 04 2016
Coverage initiated on AmSurg by Mizuho Apr 01 2016
AmSurg Corp. breached its 50 day moving average in a Bearish Manner : AMSG-US : March 16, 2016 Mar 16 2016
Today's Top 5 Stock Picks: Big Growth at a Discount Mar 16 2016
AmSurg Corp. to Present at Barclays Global Healthcare Conference Mar 09 2016
AmSurg Corp. :AMSG-US: Earnings Analysis: Q4, 2015 By the Numbers Mar 04 2016
AmSurg Corp. :AMSG-US: Earnings Analysis: Q4, 2015 By the Numbers Mar 04 2016
AmSurg Corp. breached its 50 day moving average in a Bullish Manner : AMSG-US : March 4, 2016 Mar 04 2016
AmSurg Corp. :AMSG-US: Earnings Analysis: Q4, 2015 By the Numbers Mar 03 2016
AmSurg Declares Quarterly Preferred Stock Dividend Mar 03 2016
AMSURG CORP Financials Mar 03 2016
AmSurg: Strong Q4 Raises Hope amid Bleak Cash Balance Mar 01 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK